US › Healthcare

Im Cannabis Corp (IMCC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.39+4.51%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$7.6M

Revenue YoY

-40.2%

Net profit

$-4.4M

EPS

$-0.34

Net margin

-57.5%

Key statistics

Market cap

$2.4M

Forward P/E

42.4

P/B

0.95

Book value

$-7.15

EPS (TTM)

$-71.41

52-week high

$63.60

52-week low

$1.31

50-day MA

$2.83

200-day MA

$14.08

Beta

2.21

Analyst view

with an average price target of $8.22.

Shareholding

Insiders

34.40%

Institutions

0.73%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	0.45%
Jane Street Group LLC	0.08%
StoneX Group Inc	0.05%
Hidden Cove Wealth Management, LLC	0.03%
Bank of Montreal	0.02%
BMO Capital Markets Corp.	0.02%
Federation des caisses Desjardins du Quebec	0.00%
NATIONAL BANK OF CANADA /FI/	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Im Cannabis Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.